Jefferies Raises Price Target on Ceragon Networks (CRNT) to $2.50
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/12/2026
- Wall Street ends down as US-Iran peace optimism fades
- S&P 500 EPS growth above 20% is rare. Why 2027 may be at risk
- Goldman Sachs warns AI investment may be crowding out other business spending
- Why Wednesday's inflation print could provide the next dovish catalyst
- Tesla needs Robotaxi flywheel proof to boost investor conviction: Morgan Stanley
- Lumentum Holdings (LITE) Tops Q4 EPS by 28c, Beats on Revenue; Offers Q1 Guidance
- AbCellera Biologics (ABCL) PT Raised to $30 at Truist on 'best-in-class potential'
- Aurora Cannabis rejects Curaleaf's unsolicited $4-per-share takeover bid
- Wall Street ends down as US-Iran peace optimism fades
- Comscore plans restructuring with $20M-$25M in cost cuts
- After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
- After-Hours Movers: SPCX, AMD, ANET, PINS, APPS, UPST, ZETA, BKNG, LCID, CPNG, MTCH
Pre-Open Stock Movers 11/14: (CRBP) (HAR) (DGII) (MENT) Higher; (DVAX) (HEAR) (ACM) Lower (more...)
November 14, 2016 9:24 AM ESTToday's Pre-Open Stock Movers
Dynavax Technologies (Nasdaq: DVAX) 70.7% LOWER; announced that it has received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding its Biologics License Application (BLA) for HEPLISAV-B [Hepatitis B Vaccine, Recombinant (Adjuvanted)] for immunization of adults 18 years and older against hepatitis B infection. The FDA issues CRLs to communicate that the Agency has completed a review cycle of an application and to request additional information for review and approval. Dynavax expects a Class 2 designation for a... More
Ceragon Networks (CRNT) Reports In-Line Q3 EPS
November 14, 2016 8:42 AM ESTCeragon Networks (NASDAQ: CRNT) reported Q3 EPS of $0.04, in-line with the analyst estimate of $0.04. Revenue for the quarter came in at $79.1 million versus the consensus estimate of $77.57 million.
For earnings history and earnings-related data on Ceragon Networks (CRNT) click here.
... MoreTrading Radar for 11/14: InterOil (IOC), Patriot National (PN), Netlist (NLST), Zoe's Kitchen (ZOES) Report
November 11, 2016 1:33 PM ESTThe Trading Radar highlights key earnings and economic announcements for the next trading session:
Before Markets Open:
Earnings:
AECOM Technology (NYSE: ACM) - consensus EPS $0.71
Abraxas Petroleum (Nasdaq: AXAS) - consensus loss $0.03
Akers Biosciences (Nasdaq: AKER) - no Street consensus
Aldeyra Therapeutics (Nasdaq: ALDX) - consensus loss $0.39
Amaya (NYSE: AYA) - consensus EPS $0.40
Asure Software (Nasdaq: ASUR) - consensus EPS... More
